Trends in Relative Incidence and Prevalence of Dementia Across Non-Hispanic Black and White Individuals in the United States, 2000-2016.
Journal
JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
1
12
2020
medline:
12
1
2022
entrez:
30
11
2020
Statut:
ppublish
Résumé
In the US, dementia risk is higher in non-Hispanic Black individuals than in non-Hispanic White individuals. To evaluate progress toward reducing such disparities, tracking secular trends in racial disparities in dementia prevalence is essential. To examine whether relative racial disparities in dementia prevalence or incidence have changed in the US from 2000 to 2016. The Health and Retirement Study (HRS) is a nationally representative study of adults 50 years or older. New participants are recruited every 6 years, and study visits occur biennially. Approximately 17 000 to 22 000 respondents have been surveyed at each wave since 2000, achieving response rates of 81% to 89%. Data for this cohort study were obtained from non-Hispanic White and non-Hispanic Black participants aged 70 years and older from the 2000 to 2016 waves. For analyses of secular trends in racial disparities in dementia prevalence, each HRS wave was considered separately (range of participants meeting eligibility criteria in each wave, 6322-7579). For analyses of secular trends in racial disparities in dementia incidence, 7 subcohorts were created (range of participants meeting eligibility criteria in each subcohort, 5322-5961) following up people without dementia for 4 years from subcohort baseline visits in 2000, 2002, 2004, 2006, 2008, 2010, and 2012. Data were analyzed from October 2019 to August 2020. Race based on self-response to closed-ended survey questions. Dementia status was determined using 3 algorithms with similar sensitivity and specificity across non-Hispanic White and Black participants. Disparities were characterized using ratio measures. In this study, the mean age and percentage of male participants eligible for inclusion in analyses of racial disparities in dementia prevalence increased over time among non-Hispanic White participants (from 78.2 years and 40% in 2000 to 78.7 years and 44% in 2016) but remained steady in non-Hispanic Black participants during the same period (from 78.0 years and 37% in 2000 to 77.9 years and 38% in 2016). Prevalence ratios comparing Black and White participants ranged from approximately 1.5 to 1.9 across algorithms and years, whereas hazard ratios ranged from approximately 1.4 to 1.8. Although results suggest stable or declining dementia risk overall, there was no evidence suggesting change in relative racial disparities in dementia prevalence or incidence during follow-up. This study did not find evidence to suggest that the ratio of dementia risk across Black and White individuals changed in the US between 2000 and 2016. Additional efforts to identify and mitigate the source of these disparities is warranted.
Identifiants
pubmed: 33252617
pii: 2773647
doi: 10.1001/jamaneurol.2020.4471
pmc: PMC7953306
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
275-284Subventions
Organisme : NIA NIH HHS
ID : R03 AG055485
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Neuropsychol Rev. 2008 Sep;18(3):223-54
pubmed: 18815889
J Alzheimers Dis. 2017 Oct 3;60(3):1065-1075
pubmed: 28984588
J Gerontol B Psychol Sci Soc Sci. 2018 Apr 16;73(suppl_1):S29-S37
pubmed: 29669102
J Gerontol B Psychol Sci Soc Sci. 2015 Jul;70(4):557-67
pubmed: 24584038
Neurology. 2007 Dec 11;69(24):2197-204
pubmed: 17568013
J Health Soc Behav. 2010;51 Suppl:S15-27
pubmed: 20943580
BMJ. 2006 Apr 22;332(7547):967-9
pubmed: 16627518
BMJ. 2013 Dec 19;347:f7051
pubmed: 24355614
Alzheimers Dement. 2014 Mar;10(2):e40-6
pubmed: 24698031
N Engl J Med. 2016 Feb 11;374(6):523-32
pubmed: 26863354
Ethn Dis. 2015 Aug 07;25(3):245-54
pubmed: 26675362
Epidemiology. 2019 Mar;30(2):291-302
pubmed: 30461528
J Alzheimers Dis. 2018;66(2):653-680
pubmed: 30347617
Neurology. 2020 Aug 4;95(5):e519-e531
pubmed: 32611641
J Alzheimers Dis. 2015;50(1):71-6
pubmed: 26639973
Biometrics. 2000 Jun;56(2):645-6
pubmed: 10877330
Alzheimers Res Ther. 2016 Jul 30;8(1):23
pubmed: 27473681
JAMA Intern Med. 2017 Jan 1;177(1):51-58
pubmed: 27893041
J Gerontol B Psychol Sci Soc Sci. 2011 Jul;66 Suppl 1:i162-71
pubmed: 21743047
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
Annu Rev Public Health. 2019 Apr 1;40:105-125
pubmed: 30601726
Health Serv Res. 2019 Dec;54 Suppl 2:1374-1388
pubmed: 31663121
Nat Rev Neurol. 2017 Jun;13(6):327-339
pubmed: 28497805
Epidemiology. 2020 Jan;31(1):126-133
pubmed: 31567393
J Epidemiol Community Health. 2010 Sep;64(9):747-9
pubmed: 20584723
Psychol Aging. 2017 Mar;32(2):118-130
pubmed: 28287782
J Gerontol B Psychol Sci Soc Sci. 2018 Apr 16;73(suppl_1):S48-S56
pubmed: 29669099
Int J Epidemiol. 2014 Apr;43(2):576-85
pubmed: 24671021
J Am Geriatr Soc. 2004 Feb;52(2):195-204
pubmed: 14728627
Am J Geriatr Psychiatry. 2005 Nov;13(11):968-75
pubmed: 16286440
J Int Neuropsychol Soc. 2015 Oct;21(9):677-87
pubmed: 26412671
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
J Am Geriatr Soc. 2016 Aug;64(8):1716-23
pubmed: 27310494
Alzheimers Dement. 2019 Jul;15(7):995-1003
pubmed: 30240574
Alzheimers Dement (N Y). 2018 Oct 05;4:510-520
pubmed: 30364652
J Gerontol B Psychol Sci Soc Sci. 2019 Feb 15;74(3):409-418
pubmed: 28958051
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
Alzheimers Dement. 2019 Jan;15(1):1-7
pubmed: 30195482
Stroke. 2017 Jul;48(7):2013-2020
pubmed: 28596460